Xixi Lin

Essen, NW 45147, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Condensins regulate resection-dependent DNA double-strand break repair pathways in replicated chromatin.

Condensins regulate resection-dependent DNA double-strand break repair pathways in replicated chromatin.

Journal: Nucleic acids research

Published: August 06, 2025

Cell-cycle-specific lesion evolution rather than inhibition of double-strand-break repair underpins cisplatin radiosensitization.

Cell-cycle-specific lesion evolution rather than inhibition of double-strand-break repair underpins cisplatin radiosensitization.

Journal: Molecular oncology

Published: July 31, 2025

Homologous Recombination and Alternative End-Joining Repair Pathways are Important Determinants of Radiosensitivity to Proton Radiation Therapy.

Homologous Recombination and Alternative End-Joining Repair Pathways are Important Determinants of Radiosensitivity to Proton Radiation Therapy.

Journal: International journal of radiation oncology, biology, physics

Published: June 26, 2025

Reversing regulatory safeguards: Targeting the ATR pathway to overcome PARP inhibitor resistance.

Reversing regulatory safeguards: Targeting the ATR pathway to overcome PARP inhibitor resistance.

Journal: Molecular therapy. Oncology

Published: February 19, 2025

Talazoparib enhances resection at DSBs and renders HR-proficient cancer cells susceptible to Polθ inhibition.

Talazoparib enhances resection at DSBs and renders HR-proficient cancer cells susceptible to Polθ inhibition.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: December 19, 2023

A seven-immune-genes risk model predicts the survival and suitable treatments for patients with skin cutaneous melanoma.

A seven-immune-genes risk model predicts the survival and suitable treatments for patients with skin cutaneous melanoma.

Journal: Heliyon

Published: December 16, 2022

BMN673 Is a PARP Inhibitor with Unique Radiosensitizing Properties: Mechanisms and Potential in Radiation Therapy.

BMN673 Is a PARP Inhibitor with Unique Radiosensitizing Properties: Mechanisms and Potential in Radiation Therapy.

Journal: Cancers

Published: October 07, 2022

Chances and challenges-analysis of trends in breast reconstruction.

Chances and challenges-analysis of trends in breast reconstruction.

Journal: Journal of plastic, reconstructive & aesthetic surgery : JPRAS

Published: September 16, 2021

Showing 1-8 of 8

Last Updated: 09/26/2026